101 related articles for article (PubMed ID: 6661370)
1. The clinical pharmacology of chlorambucil and prednimustine.
Newell DR; Calvert AH; Harrap KR; McElwain TJ
Br J Clin Pharmacol; 1983 Dec; 16(6):762-3. PubMed ID: 6661370
[No Abstract] [Full Text] [Related]
2. On the clinical pharmacology of prednimustine.
Plym Forshell G; Gunnarsson PO; Liljekvist J
Br J Clin Pharmacol; 1983 Dec; 16(6):760-1. PubMed ID: 6661369
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).
Ehrsson H; Wallin I; Nilsson SO; Johansson B
Eur J Clin Pharmacol; 1983; 24(2):251-3. PubMed ID: 6840176
[TBL] [Abstract][Full Text] [Related]
4. Studies on the pharmacokinetics of chlorambucil and prednimustine in man.
Newell DR; Calvert AH; Harrap KR; McElwain TJ
Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of prednimustine and chlorambucil in the rat.
Newell DR; Shepherd CR; Harrap KR
Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.
Hartley-Asp B; Gunnarsson PO; Liljekvist J
Cancer Chemother Pharmacol; 1986; 16(2):85-90. PubMed ID: 3948307
[TBL] [Abstract][Full Text] [Related]
7. The antitumor effect of prednimustine in vitro and in vivo.
Hartley-Asp B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):3-7. PubMed ID: 3952519
[TBL] [Abstract][Full Text] [Related]
8. Prednimustine: the rationale for clinical development.
Schein PS; Cavalli F
Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-2. PubMed ID: 3952515
[No Abstract] [Full Text] [Related]
9. Prednisolone plasma levels after oral administration of Prednimustine. Comparison with levels obtained after administration of an equimolar dose of prednisolone.
Sayed A; Hove WV; Vermeulen A
Oncology; 1981; 38(6):351-5. PubMed ID: 7301281
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the cytotoxic effect of prednimustine in cultured cells with high or low levels of metallothionein.
Endresen L
Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):49-57. PubMed ID: 6702467
[TBL] [Abstract][Full Text] [Related]
11. Disposition of orally administered 14C-prednimustine in cancer patients.
Gaver RC; Deeb G; Pittman KA; Issell BF; Mittelman A; Smyth RD
Cancer Chemother Pharmacol; 1983; 11(3):139-43. PubMed ID: 6640823
[TBL] [Abstract][Full Text] [Related]
12. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.
Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B
Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378
[TBL] [Abstract][Full Text] [Related]
13. Preliminary clinical study of prednimustine in lung cancer.
Catane H; Catane R; Takita H; Kaufman JH; Mittelman A; Murphy GP
J Med; 1977; 8(2):115-21. PubMed ID: 268397
[TBL] [Abstract][Full Text] [Related]
14. Comparative carcinogenic activity of prednimustine, chlorambucil, prednisolone and chlorambucil plus prednisolone in Sprague-Dawley rats.
Berger MR; Habs M; Schmähl D
Arch Geschwulstforsch; 1985; 55(6):429-42. PubMed ID: 4083998
[TBL] [Abstract][Full Text] [Related]
15. Prednimustine treatment in malignant lymphomas.
Szántó I; Fleischmann T; Eckhardt S
Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
[TBL] [Abstract][Full Text] [Related]
16. Estimation of chlorambucil, phenyl acetic mustard and prednimustine in human plasma by high-performance liquid chromatography.
Newell DR; Hart LI; Harrap KR
J Chromatogr; 1979 Sep; 164(1):114-9. PubMed ID: 541393
[No Abstract] [Full Text] [Related]
17. Prednimustine.
Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-44. PubMed ID: 3952516
[No Abstract] [Full Text] [Related]
18. Long-term toxicology effects of prednimustine in comparison with chlorambucil, prednisolone, and chlorambucil plus prednisolone in Sprague-Dawley rats.
Berger MR; Habs M; Schmähl D
Semin Oncol; 1986 Mar; 13(1 Suppl 1):8-13. PubMed ID: 3952521
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung.
Jensen HS; Hansen HH; Dombernowsky P
Cancer Chemother Pharmacol; 1980; 4(4):259-61. PubMed ID: 6254684
[TBL] [Abstract][Full Text] [Related]
20. Prednimustine in advanced breast cancer: a review.
Mouridsen HT
Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]